(FIVN) Five9 - Overview
Stock: Cloud Platform, Virtual Agent, Agent Assist, Workflow Automation
| Risk 5d forecast | |
|---|---|
| Volatility | 55.8% |
| Relative Tail Risk | -8.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.23 |
| Alpha | -75.33 |
| Character TTM | |
|---|---|
| Beta | 1.796 |
| Beta Downside | 1.770 |
| Drawdowns 3y | |
|---|---|
| Max DD | 81.79% |
| CAGR/Max DD | -0.43 |
EPS (Earnings per Share)
Revenue
Description: FIVN Five9 January 14, 2026
Five9, Inc. (NASDAQ:FIVN) delivers an intelligent, cloud-based customer-experience (CX) platform that unifies voice, chat, email, web, social and mobile channels. Its suite includes AI-driven virtual agents, agent-assist tools, workflow automation, workforce-engagement management, and real-time data integration with enterprise systems such as CRM, enabling firms to route interactions efficiently and boost agent productivity.
In FY 2023 the company reported $1.06 billion in revenue, representing a 21 % year-over-year increase, with non-GAAP operating margin expanding to 14 % and annual recurring revenue (ARR) surpassing $2.1 billion. Customer churn remained low at roughly 4 % on a contract-value basis, indicating strong stickiness in a market where average contract sizes are trending upward (≈ $250 k per customer). These metrics suggest Five9 is capturing a meaningful share of the growing cloud-contact-center spend.
The primary macro drivers for Five9 are the broader shift from on-premise to SaaS contact-center solutions (the cloud-contact-center market is projected to grow at a CAGR of ~13 % through 2028) and accelerating adoption of generative AI to reduce labor costs and improve service quality. Additionally, tighter labor markets in the U.S. and Europe increase demand for automation tools that can augment human agents, while regulatory pressure in banking and healthcare pushes firms toward integrated, audit-ready CX platforms.
For a deeper, data-driven view of Five9’s valuation relative to its peers, you may find it useful to explore the analytics available on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 39.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.22 > 1.0 |
| NWC/Revenue: 64.98% < 20% (prev 58.25%; Δ 6.74% < -1%) |
| CFO/TA 0.11 > 3% & CFO 192.5m > Net Income 39.4m |
| Net Debt (573.0m) to EBITDA (105.0m): 5.46 < 3 |
| Current Ratio: 4.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.0m) vs 12m ago -1.81% < -2% |
| Gross Margin: 55.07% > 18% (prev 0.54%; Δ 5453 % > 0.5%) |
| Asset Turnover: 59.83% > 50% (prev 50.80%; Δ 9.03% > 0%) |
| Interest Coverage Ratio: 3.10 > 6 (EBITDA TTM 105.0m / Interest Expense TTM 7.97m) |
Altman Z'' 1.74
| A: 0.42 (Total Current Assets 959.7m - Total Current Liabilities 213.0m) / Total Assets 1.79b |
| B: -0.21 (Retained Earnings -378.2m / Total Assets 1.79b) |
| C: 0.01 (EBIT TTM 24.7m / Avg Total Assets 1.92b) |
| D: -0.38 (Book Value of Equity -377.3m / Total Liabilities 1.00b) |
| Altman-Z'' Score: 1.74 = BBB |
Beneish M -2.99
| DSRI: 0.97 (Receivables 131.0m/122.4m, Revenue 1.15b/1.04b) |
| GMI: 0.98 (GM 55.07% / 54.17%) |
| AQI: 1.16 (AQ_t 0.34 / AQ_t-1 0.29) |
| SGI: 1.10 (Revenue 1.15b / 1.04b) |
| TATA: -0.09 (NI 39.4m - CFO 192.5m) / TA 1.79b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of FIVN shares?
Over the past week, the price has changed by +15.34%, over one month by +12.65%, over three months by +8.66% and over the past year by -53.66%.
Is FIVN a buy, sell or hold?
- StrongBuy: 12
- Buy: 6
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the FIVN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32.4 | 67.6% |
| Analysts Target Price | 32.4 | 67.6% |
FIVN Fundamental Data Overview February 21, 2026
P/E Forward = 5.2493
P/S = 1.1918
P/B = 1.6909
P/EG = 0.5841
Revenue TTM = 1.15b USD
EBIT TTM = 24.7m USD
EBITDA TTM = 105.0m USD
Long Term Debt = 734.6m USD (from longTermDebt, two quarters ago)
Short Term Debt = 21.4m USD (from shortTermDebt, last quarter)
Debt = 805.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 573.0m USD (from netDebt column, last quarter)
Enterprise Value = 1.92b USD (1.34b + Debt 805.1m - CCE 232.1m)
Interest Coverage Ratio = 3.10 (Ebit TTM 24.7m / Interest Expense TTM 7.97m)
EV/FCF = 13.92x (Enterprise Value 1.92b / FCF TTM 137.7m)
FCF Yield = 7.18% (FCF TTM 137.7m / Enterprise Value 1.92b)
FCF Margin = 11.98% (FCF TTM 137.7m / Revenue TTM 1.15b)
Net Margin = 3.43% (Net Income TTM 39.4m / Revenue TTM 1.15b)
Gross Margin = 55.07% ((Revenue TTM 1.15b - Cost of Revenue TTM 516.2m) / Revenue TTM)
Gross Margin QoQ = 56.22% (prev 54.19%)
Tobins Q-Ratio = 1.07 (Enterprise Value 1.92b / Total Assets 1.79b)
Interest Expense / Debt = -0.38% (Interest Expense -3.05m / Debt 805.1m)
Taxrate = 14.40% (3.32m / 23.0m)
NOPAT = 21.1m (EBIT 24.7m * (1 - 14.40%))
Current Ratio = 4.51 (Total Current Assets 959.7m / Total Current Liabilities 213.0m)
Debt / Equity = 1.02 (Debt 805.1m / totalStockholderEquity, last quarter 785.8m)
Debt / EBITDA = 5.46 (Net Debt 573.0m / EBITDA 105.0m)
Debt / FCF = 4.16 (Net Debt 573.0m / FCF TTM 137.7m)
Total Stockholder Equity = 735.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.05% (Net Income 39.4m / Total Assets 1.79b)
RoE = 5.36% (Net Income TTM 39.4m / Total Stockholder Equity 735.7m)
RoCE = 1.68% (EBIT 24.7m / Capital Employed (Equity 735.7m + L.T.Debt 734.6m))
RoIC = 1.32% (NOPAT 21.1m / Invested Capital 1.60b)
WACC = 7.71% (E(1.34b)/V(2.15b) * Re(12.53%) + D(805.1m)/V(2.15b) * Rd(-0.38%) * (1-Tc(0.14)))
Discount Rate = 12.53% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 9.25%
[DCF Debug] Terminal Value 80.08% ; FCFF base≈111.1m ; Y1≈118.8m ; Y5≈143.8m
Fair Price DCF = 26.52 (EV 2.65b - Net Debt 573.0m = Equity 2.07b / Shares 78.2m; r=7.71% [WACC]; 5y FCF grow 7.73% → 2.90% )
EPS Correlation: 88.47 | EPS CAGR: 41.09% | SUE: 0.51 | # QB: 0
Revenue Correlation: 99.09 | Revenue CAGR: 14.16% | SUE: 0.49 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.66 | Chg30d=+0.001 | Revisions Net=+1 | Analysts=21
EPS current Year (2026-12-31): EPS=3.18 | Chg30d=-0.006 | Revisions Net=+1 | Growth EPS=+7.4% | Growth Revenue=+9.2%
EPS next Year (2027-12-31): EPS=3.54 | Chg30d=+0.002 | Revisions Net=+2 | Growth EPS=+11.5% | Growth Revenue=+9.3%